PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27220989-7	2016	In addition, combination treatment with 7,8-DHF and resveratrol, a known therapeutic agent against melanoma, had greater anticancer activities and MITF inhibition than treatment with each single agent in alpha-MSH-treated B16F10 cells.	Resveratrol	52-63	pro-opiomelanocortin-alpha	Mus musculus	204-213	
27390733-0	2016	Comparative Depigmentation Effects of Resveratrol and Its Two Methyl Analogues in alpha-Melanocyte Stimulating Hormone-Triggered B16/F10 Murine Melanoma Cells.	Resveratrol	38-49	pro-opiomelanocortin-alpha	Mus musculus	82-118	
23762150-0	2013	Resveratrol inhibits alpha-melanocyte-stimulating hormone signaling, viability, and invasiveness in melanoma cells.	Resveratrol	0-11	pro-opiomelanocortin-alpha	Mus musculus	21-57	
23762150-3	2013	This study was aimed to examine the effect of resveratrol, an abundant ingredient of grape and medicinal plants, on alpha -MSH signaling, viability, and invasiveness in melanoma cells.	Resveratrol	46-57	pro-opiomelanocortin-alpha	Mus musculus	116-126	
23762150-5	2013	The upregulated expression of alpha -MSH signaling-related molecules beta -catenin, c-Kit, and MITF was suppressed by resveratrol and/or STI571 treatment.	Resveratrol	118-129	pro-opiomelanocortin-alpha	Mus musculus	30-40	
23762150-6	2013	Nuclear translocation of MITF, a hallmark of alpha -MSH signaling activation, was inhibited by combined treatment of resveratrol and STI571.	Resveratrol	117-128	pro-opiomelanocortin-alpha	Mus musculus	45-55	
23762150-8	2013	In conclusion, resveratrol enhances STI571 effect on suppressing the alpha -MSH signaling, viability, and invasiveness in melanoma cells.	Resveratrol	15-26	pro-opiomelanocortin-alpha	Mus musculus	69-79